Lisa Graf
Lisa Graf is the Director of Clinical Projects at Redenlab, where she leads the planning and [...]
About Us
Clinical experience, extensive research record of accomplishment, and innovative products.
Redenlab's Overview
Communication is a core human function, and measuring its decline through objective biomarkers is critical to understanding overall disease severity and functional quality of life, which is often missed by conventional assessments
Redenlab is a neuroscience clinical outcome assessment technology company founded in 2017. We specialise in the development and application of speech, language, swallowing, and audio biomarkers for clinical trials and healthcare research. Our proven digital speech platform delivers objective measurements of communication and other quality of life abilities, supporting the evaluation of treatment efficacy and ongoing patient health monitoring. Our team, which includes trained clinicians and engineers, ensures that all product development is grounded in robust science and clinical utility. Over a decade, we have partnered with a diverse range of clients, including leading pharmaceutical and biotech companies, medical clinics, and academic research institutions, solidifying our reputation as a trusted innovator in the field.
1. Clinically rigorous
We engage directly with key opinion leaders, clinics, and clinicians around the world to ensure our work is current and rooted in clinical practice. Combining our own clinical experience, extensive research record of accomplishment, and innovative products, we are leaders in the field.
2. Collaborative
Our flexible approach to working with partners fosters long term relationships, including collaborations with not-for-profit organisations, research groups and regulators to enhance our capabilities.
3. Pioneering
As the first to market in this space, we remain at the forefront of innovation, shaping the direction of outcome development and setting benchmarks for the industry. Our work is global, with trials and staff worldwide, and we actively seek out challenges and studies beyond mainstream speech analysis.
4. Patient centric
Our focus is always on patients. By actively listening to consumers and patient advocacy groups and addressing their interests and concerns related to their disease profiles, we consistently prioritise their needs, setting us apart from competitors.
Our Team
Working with a global team of over 30 specialised staff, our leadership brings deep expertise in neuroscience, technology, and healthcare, driving innovation in clinical outcome assessment.
Thayabaran Kathiresan PhD
Thayabaran currently serves as the Senior Director of Speech Science at Redenlab. In this role, Thaya [...]
Paul Maruff
Dr. Paul Maruff, previously a member of our advisory board, has joined the Redenlab management team [...]
Geoff Stuart
Dr Geoff Stuart PHD is Redenlab’s lead Statistician, supervising clinical trial statistics and data analytics. He [...]
Devon Borysiewicz
Devon is Vice President of Technology and Software Engineering at Redenlab. Introduced to the technology sector [...]
Gloria Macan
Gloria Macan is the Director of Marketing and Communications at Redenlab, where she brings a wealth [...]
Adam Vogel
Adam Vogel PhD is the Chief Science Officer and Founder of Redenlab. He currently serves as [...]
Advisory Board
Our advisory board includes experts in neuroscience, technology, healthcare, legal, and finance. Their guidance helps us drive innovation in speech assessment, ensuring we deliver innovative solutions for clinical trials and patient care worldwide.
Arvind Tewari
Dr. Peter Gibilisco
James Fletcher
Roger O’Sullivan
Ramesh Rajan
Transforming care: Redenlab's commitment to patients and innovation
Redenlab continues to set the benchmark of innovative clinical assessment in drug discovery and research pipelines. We are dedicated to delivering exceptional benefits to patients and sponsors by measuring what truly matters. Through a blend of world leading research, pioneering solutions, and a collaborative mind-set, we actively engage with patients and partners alike to shape the future of clinical trials. From addressing individual needs with empathy to setting industry standards in technology development, our mission is to transform care through meaningful measurement.
Your Partner in Clinical Excellence
We collaborate with CROs, sponsors, and clinical teams to deliver validated tools and insights tailored to your clinical trial needs.
